{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T15:36:28Z","timestamp":1786116988943,"version":"build-2736575974"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T00:00:00Z","timestamp":1785974400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T00:00:00Z","timestamp":1785974400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Luzhou Science and Technology Program","award":["2024JYJ061"],"award-info":[{"award-number":["2024JYJ061"]}]},{"name":"Southwest Medical University research project","award":["2024ZKZ005"],"award-info":[{"award-number":["2024ZKZ005"]}]},{"name":"Sichuan Science and Technology Support Project","award":["2022YFS0636"],"award-info":[{"award-number":["2022YFS0636"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1007\/s11033-026-12268-x","type":"journal-article","created":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T13:00:28Z","timestamp":1786021228000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["eIF6 affects the occurrence and development of esophageal cancer"],"prefix":"10.1007","volume":"53","author":[{"given":"Cong-Gai","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ran","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui-Ling","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen-Xi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fei","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Lei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiong","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi-Hui","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,6]]},"reference":[{"issue":"3","key":"12268_CR1","first-page":"165","volume":"33","author":"W Shaoming","year":"2024","unstructured":"Shaoming W, Rongshou Z, Bingfeng H et al (2024) Age Distribution of Cancer Incidence and Mortality in China in 2022. Chinese tumor 33(3):165\u2013174","journal-title":"Chinese tumor"},{"issue":"3","key":"12268_CR2","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3322\/caac.21834","volume":"74","author":"F Bray","year":"2022","unstructured":"Bray F, Laversanne M, Sung H et al (2022) Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 74(3):229\u2013263. https:\/\/doi.org\/10.3322\/caac.21834","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"12268_CR3","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-023-01839-2","volume":"22","author":"L An","year":"2023","unstructured":"An L, Li M, Jia Q (2023) Mechanisms of radiotherapy resistance and radiosensitization strategies for esophageal squamous cell carcinoma. Mol Cancer 22(1):140. https:\/\/doi.org\/10.1186\/s12943-023-01839-2","journal-title":"Mol Cancer"},{"issue":"2","key":"12268_CR4","doi-asserted-by":"publisher","DOI":"10.3390\/jcm7020033","volume":"7","author":"TK Oh","year":"2018","unstructured":"Oh TK, Kim K, Jheon SH et al (2018) Long-term oncologic outcomes, opioid use, and complications after esophageal cancer surgery. J Clin Med 7(2):33. https:\/\/doi.org\/10.3390\/jcm7020033","journal-title":"J Clin Med"},{"issue":"5","key":"12268_CR5","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1097\/CM9.0000000000002108","volume":"135","author":"C Xia","year":"2022","unstructured":"Xia C, Dong X, Li H et al (2022) Cancer statistics in China and United States, 2022: profiles, trends, and determinants. Chin Med J (Engl) 135(5):584\u2013590. https:\/\/doi.org\/10.1097\/CM9.0000000000002108","journal-title":"Chin Med J (Engl)"},{"issue":"1","key":"12268_CR6","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.ydbio.2019.05.013","volume":"455","author":"A Russo","year":"2019","unstructured":"Russo A, Gatti G, Alfieri R et al (2019) Modulating eIF6 levels unveils the role of translation in ecdysone biosynthesis during Drosophila development. Dev Biol 455(1):100\u2013111. https:\/\/doi.org\/10.1016\/j.ydbio.2019.05.013","journal-title":"Dev Biol"},{"issue":"1","key":"12268_CR7","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-026-69899-8","volume":"17","author":"H Peng","year":"2026","unstructured":"Peng H, Wang Z, Wang M et al (2026) Eukaryote initiation factor 6 modulates small-cell lung carcinoma plasticity via the integrin-FAK signaling axis. Nat Commun 17(1):2048. https:\/\/doi.org\/10.1038\/s41467-026-69899-8","journal-title":"Nat Commun"},{"issue":"1","key":"12268_CR8","doi-asserted-by":"publisher","DOI":"10.1007\/s00018-025-05766-x","volume":"82","author":"X Li","year":"2025","unstructured":"Li X, Xia Y, Li X et al (2025) PRDM16 acts as a homeostasis regulation factor to suppress the transition of AKI to CKD via upregulation of eukaryotic initiation factor 6. Cell Mol Life Sci 82(1):252. https:\/\/doi.org\/10.1007\/s00018-025-05766-x","journal-title":"Cell Mol Life Sci"},{"issue":"5","key":"12268_CR9","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24054885","volume":"24","author":"A Scagliola","year":"2023","unstructured":"Scagliola A, Miluzio A, Biffo S (2023) Translational control of metabolism and cell cycle progression in hepatocellular carcinoma. Int J Mol Sci 24(5):4885. https:\/\/doi.org\/10.3390\/ijms24054885","journal-title":"Int J Mol Sci"},{"key":"12268_CR10","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.ejca.2018.07.001","volume":"101","author":"N Gantenbein","year":"2018","unstructured":"Gantenbein N, Bernhart E, Anders I et al (2018) Influence of eukaryotic translation initiation factor 6 on non-small cell lung cancer development and progression. Eur J Cancer 101:165\u2013180. https:\/\/doi.org\/10.1016\/j.ejca.2018.07.001","journal-title":"Eur J Cancer"},{"issue":"12","key":"12268_CR11","doi-asserted-by":"publisher","first-page":"e00070","DOI":"10.1128\/MCB.00070-18","volume":"38","author":"PP Roux","year":"2018","unstructured":"Roux PP, Topisirovic I (2018) Signaling Pathways Involved in the Regulation of mRNA Translation. Mol Cell Biol 38(12):e00070-e118. https:\/\/doi.org\/10.1128\/MCB.00070-18","journal-title":"Mol Cell Biol"},{"issue":"1","key":"12268_CR12","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-021-02877-4","volume":"19","author":"L Sun","year":"2021","unstructured":"Sun L, Liu S, Wang X, Zheng X, Chen Y, Shen H (2021) EIF6 promotes the malignant progression of human hepatocellular carcinoma via the mTOR signaling pathway. J Transl Med 19(1):216. https:\/\/doi.org\/10.1186\/s12967-021-02877-4","journal-title":"J Transl Med"},{"key":"12268_CR13","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.817916","volume":"12","author":"R Huang","year":"2022","unstructured":"Huang R, Dai Q, Yang R et al (2022) A review: PI3K\/AKT\/mTOR signaling pathway and its regulated eukaryotic translation initiation factors may be a potential therapeutic target in esophageal squamous cell carcinoma. Front Oncol 12:817916. https:\/\/doi.org\/10.3389\/fonc.2022.817916","journal-title":"Front Oncol"},{"issue":"3","key":"12268_CR14","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1016\/j.cell.2018.09.018","volume":"175","author":"M Angelova","year":"2018","unstructured":"Angelova M, Mlecnik B, Vasaturo A et al (2018) Evolution of metastases in space and time under immune selection. Cell 175(3):751-765 e16. https:\/\/doi.org\/10.1016\/j.cell.2018.09.018","journal-title":"Cell"},{"issue":"5","key":"12268_CR15","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1093\/neuonc\/nop059","volume":"12","author":"E Chautard","year":"2010","unstructured":"Chautard E, Loubeau G, Tchirkov A et al (2010) Akt signaling pathway: a target for radiosensitizing human malignant glioma. Neuro Oncol 12(5):434\u2013343. https:\/\/doi.org\/10.1093\/neuonc\/nop059","journal-title":"Neuro Oncol"},{"issue":"2","key":"12268_CR16","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1016\/j.immuni.2019.01.020","volume":"50","author":"JB Wing","year":"2019","unstructured":"Wing JB, Tanaka A, Sakaguchi S (2019) Human FOXP3(+) regulatory T cell heterogeneity and function in autoimmunity and cancer. Immunity 50(2):302\u2013316. https:\/\/doi.org\/10.1016\/j.immuni.2019.01.020","journal-title":"Immunity"},{"issue":"2","key":"12268_CR17","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1038\/s41580-018-0080-4","volume":"20","author":"A Dongre","year":"2019","unstructured":"Dongre A, Weinberg RA (2019) New insights into the mechanisms of epithelial-mesenchymal transition and implications for cancer. Nat Rev Mol Cell Biol 20(2):69\u201384. https:\/\/doi.org\/10.1038\/s41580-018-0080-4","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"4070","key":"12268_CR18","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1126\/science.179.4070.295","volume":"179","author":"RL Trelstad","year":"1973","unstructured":"Trelstad RL, Kang AH, Cohen AM, Hay ED (1973) Collagen synthesis in vitro by embryonic spinal cord epithelium. Science 179(4070):295\u2013297. https:\/\/doi.org\/10.1126\/science.179.4070.295","journal-title":"Science"},{"issue":"9","key":"12268_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbadis.2022.166431","volume":"1868","author":"R Gundamaraju","year":"1868","unstructured":"Gundamaraju R, Lu W, Paul MK et al (1868) Autophagy and EMT in cancer and metastasis: who controls whom? Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 1868(9):166431. https:\/\/doi.org\/10.1016\/j.bbadis.2022.166431","journal-title":"Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease"},{"issue":"5","key":"12268_CR20","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1111\/febs.16334","volume":"289","author":"A Nachiyappan","year":"2022","unstructured":"Nachiyappan A, Gupta N, Taneja R (2022) EHMT1\/EHMT2 in EMT, cancer stemness and drug resistance: emerging evidence and mechanisms. FEBS J 289(5):1329\u20131351. https:\/\/doi.org\/10.1111\/febs.16334","journal-title":"FEBS J"},{"issue":"6","key":"12268_CR21","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1038\/s41388-021-02119-3","volume":"41","author":"M Li","year":"2022","unstructured":"Li M, Rao X, Cui Y et al (2022) The keratin 17\/YAP\/IL6 axis contributes to E-cadherin loss and aggressiveness of diffuse gastric cancer. Oncogene 41(6):770\u2013781. https:\/\/doi.org\/10.1038\/s41388-021-02119-3","journal-title":"Oncogene"},{"key":"12268_CR22","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2024.1470379","volume":"14","author":"N Bar-Hai","year":"2024","unstructured":"Bar-Hai N, Ben-Yishay R, Arbili-Yarhi S et al (2024) Modeling epithelial-mesenchymal transition in patient-derived breast cancer organoids. Front Oncol 14:1470379. https:\/\/doi.org\/10.3389\/fonc.2024.1470379","journal-title":"Front Oncol"},{"issue":"4","key":"12268_CR23","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1006\/meth.2001.1262","volume":"25","author":"KJ Livak","year":"2001","unstructured":"Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25(4):402\u2013408. https:\/\/doi.org\/10.1006\/meth.2001.1262","journal-title":"Methods"},{"issue":"7","key":"12268_CR24","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1093\/intimm\/dxm057","volume":"19","author":"T Okazaki","year":"2007","unstructured":"Okazaki T, Honjo T (2007) PD-1 and PD-1 ligands: from discovery to clinical application. Int Immunol 19(7):813\u2013824. https:\/\/doi.org\/10.1093\/intimm\/dxm057","journal-title":"Int Immunol"},{"issue":"26","key":"12268_CR25","doi-asserted-by":"publisher","first-page":"2517","DOI":"10.1056\/NEJMoa1104621","volume":"364","author":"C Robert","year":"2011","unstructured":"Robert C, Thomas L, Bondarenko I et al (2011) Ipilimumab plus dacarbazine for previously untreated metastatic melanoma. N Engl J Med 364(26):2517\u20132526. https:\/\/doi.org\/10.1056\/NEJMoa1104621","journal-title":"N Engl J Med"},{"issue":"5","key":"12268_CR26","doi-asserted-by":"publisher","first-page":"561","DOI":"10.3978\/j.issn.2078-6891.2015.037","volume":"6","author":"AG Raufi","year":"2015","unstructured":"Raufi AG, Klempner SJ (2015) Immunotherapy for advanced gastric and esophageal cancer: preclinical rationale and ongoing clinical investigations. J Gastrointest Oncol 6(5):561\u2013569. https:\/\/doi.org\/10.3978\/j.issn.2078-6891.2015.037","journal-title":"J Gastrointest Oncol"},{"issue":"2","key":"12268_CR27","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.annonc.2019.10.018","volume":"31","author":"M Moehler","year":"2020","unstructured":"Moehler M, Maderer A, Thuss-Patience PC et al (2020) Cisplatin and 5-fluorouracil with or without epidermal growth factor receptor inhibition panitumumab for patients with non-resectable, advanced or metastatic oesophageal squamous cell cancer: a prospective, open-label, randomised phase III AIO\/EORTC trial (POWER). Ann Oncol 31(2):228\u2013235. https:\/\/doi.org\/10.1016\/j.annonc.2019.10.018","journal-title":"Ann Oncol"},{"issue":"26","key":"12268_CR28","doi-asserted-by":"publisher","first-page":"2443","DOI":"10.1056\/NEJMoa1200690","volume":"366","author":"SL Topalian","year":"2012","unstructured":"Topalian SL, Hodi FS, Brahmer JR et al (2012) Safety, activity, and immune correlates of anti-PD-1 antibody in cancer. N Engl J Med 366(26):2443\u20132454. https:\/\/doi.org\/10.1056\/NEJMoa1200690","journal-title":"N Engl J Med"},{"issue":"34","key":"12268_CR29","doi-asserted-by":"publisher","first-page":"4015","DOI":"10.1200\/JCO.2015.62.3397","volume":"33","author":"J Hamanishi","year":"2015","unstructured":"Hamanishi J, Mandai M, Ikeda T et al (2015) Safety and antitumor activity of anti-PD-1 antibody, nivolumab, in patients with platinum-resistant ovarian cancer. J Clin Oncol 33(34):4015\u20134022. https:\/\/doi.org\/10.1200\/JCO.2015.62.3397","journal-title":"J Clin Oncol"},{"issue":"19","key":"12268_CR30","doi-asserted-by":"publisher","first-page":"3167","DOI":"10.1200\/JCO.2009.26.7609","volume":"28","author":"JR Brahmer","year":"2010","unstructured":"Brahmer JR, Drake CG, Wollner I et al (2010) Phase I study of single-agent anti-programmed death-1 (MDX-1106) in refractory solid tumors: safety, clinical activity, pharmacodynamics, and immunologic correlates. J Clin Oncol 28(19):3167\u20133175. https:\/\/doi.org\/10.1200\/JCO.2009.26.7609","journal-title":"J Clin Oncol"},{"key":"12268_CR31","doi-asserted-by":"publisher","DOI":"10.1126\/science.aan2507","author":"M Uhlen","year":"2017","unstructured":"Uhlen M, Zhang C, Lee S et al (2017) A pathology atlas of the human cancer transcriptome. Science. https:\/\/doi.org\/10.1126\/science.aan2507","journal-title":"Science"},{"key":"12268_CR32","doi-asserted-by":"publisher","DOI":"10.1186\/s12964-021-00800-4","author":"Z Zhao","year":"2021","unstructured":"Zhao Z, Chu W, Zheng Y et al (2021) Cytoplasmic eIF6 promotes OSCC malignant behavior through AKT pathway. Cell Commun Signal. https:\/\/doi.org\/10.1186\/s12964-021-00800-4","journal-title":"Cell Commun Signal"},{"issue":"1","key":"12268_CR33","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-023-11028-5","volume":"23","author":"WZ Wang","year":"2023","unstructured":"Wang WZ, Cao X, Bian L et al (2023) Analysis of mRNA-miRNA interaction network reveals the role of CAFs-derived exosomes in the immune regulation of oral squamous cell carcinoma. BMC Cancer 23(1):591. https:\/\/doi.org\/10.1186\/s12885-023-11028-5","journal-title":"BMC Cancer"},{"issue":"6","key":"12268_CR34","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1002\/mc.22985","volume":"58","author":"QW Zhang","year":"2019","unstructured":"Zhang QW, Zhang XT, Tang CT, Lin XL, Ge ZZ, Li XB (2019) EGFL6 promotes cell proliferation in colorectal cancer via regulation of the WNT\/beta-catenin pathway. Mol Carcinog 58(6):967\u2013979. https:\/\/doi.org\/10.1002\/mc.22985","journal-title":"Mol Carcinog"},{"issue":"14","key":"12268_CR35","doi-asserted-by":"publisher","first-page":"4141","DOI":"10.7150\/thno.35033","volume":"9","author":"Q Zou","year":"2019","unstructured":"Zou Q, Xiao Z, Huang R et al (2019) Survey of the translation shifts in hepatocellular carcinoma with ribosome profiling. Theranostics 9(14):4141\u20134155. https:\/\/doi.org\/10.7150\/thno.35033","journal-title":"Theranostics"},{"issue":"1","key":"12268_CR36","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.cell.2016.06.028","volume":"166","author":"MA Nieto","year":"2016","unstructured":"Nieto MA, Huang RY, Jackson RA, Thiery JP (2016) Emt: 2016. Cell 166(1):21\u201345. https:\/\/doi.org\/10.1016\/j.cell.2016.06.028","journal-title":"Cell"},{"issue":"1","key":"12268_CR37","doi-asserted-by":"publisher","DOI":"10.1186\/s13045-022-01347-8","volume":"15","author":"Y Huang","year":"2022","unstructured":"Huang Y, Hong W, Wei X (2022) The molecular mechanisms and therapeutic strategies of EMT in tumor progression and metastasis. J Hematol Oncol 15(1):129. https:\/\/doi.org\/10.1186\/s13045-022-01347-8","journal-title":"J Hematol Oncol"},{"issue":"55","key":"12268_CR38","doi-asserted-by":"publisher","first-page":"6958","DOI":"10.1038\/onc.2008.346","volume":"27","author":"G Moreno-Bueno","year":"2008","unstructured":"Moreno-Bueno G, Portillo F, Cano A (2008) Transcriptional regulation of cell polarity in EMT and cancer. Oncogene 27(55):6958\u20136969. https:\/\/doi.org\/10.1038\/onc.2008.346","journal-title":"Oncogene"},{"issue":"1","key":"12268_CR39","doi-asserted-by":"publisher","first-page":"3","DOI":"10.3892\/ol.2017.6161","volume":"14","author":"W Zhu","year":"2017","unstructured":"Zhu W, Li GX, Chen HL, Liu XY (2017) The role of eukaryotic translation initiation factor 6 in tumors. Oncol Lett 14(1):3\u20139. https:\/\/doi.org\/10.3892\/ol.2017.6161","journal-title":"Oncol Lett"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-026-12268-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-026-12268-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-026-12268-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T13:00:31Z","timestamp":1786021231000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11033-026-12268-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,6]]},"references-count":39,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["12268"],"URL":"https:\/\/doi.org\/10.1007\/s11033-026-12268-x","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"value":"0301-4851","type":"print"},{"value":"1573-4978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,6]]},"assertion":[{"value":"24 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study protocol was approved by the Institutional Ethics Committee of Shanghai Biochip Co., Ltd. (Shanghai, China; approval no. SHYJS-CP-1807014) and adhered to the fundamental principles of medical ethics outlined in the Declaration of Helsinki. All participating patients provided written informed consent prior to enrollment, ensuring compliance with the ethical guidelines established by the International Council of Medical Journal Editors (ICMJE) and the Declaration of Helsinki.","order":2,"name":"Ethics","label":"Ethics approval","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"1351"}}